Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China
Clinical trial NCT06846996 · RECRUITING
Trial details
- NCT number
- NCT06846996
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-27
- Primary completion
- 2027-07-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.